Join to view full profile
1001 Potrero Ave Rm 207San Francisco, CA 94110
Phone+1 415-206-5268
Dr. Mcgrath is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Stanford University School of MedicineClass of 1980
Certifications & Licensure
CA State Medical License 1983 - 2027
Publications & Presentations
PubMed
- Quantitative Measures of Time to Loss of 15% Vital Capacity and Survival Extension in Slowly Progressive Amyotrophic Lateral Sclerosis (ALS) Patients Treated with the ...Namita A Goyal, Jinsy A Andrews, Björn E Oskarsson, Martina H Wiedau, Edward J Kasarskis
Biomedicines. 2025-12-12 - 4 citationsRespiratory Function Improvement and Lifespan Extension Following Immunotherapy with NP001 Support the Concept That Amyotrophic Lateral Sclerosis (ALS) Is an Immuno-Ne...Rongzhen Zhang, Ari Azhir, Michael S McGrath
International Journal of Molecular Sciences. 2025-05-03 - 2 citationsSystemic Innate Immune System Restoration as a Therapeutic Approach for Neurodegenerative Disease: Effects of NP001 on Amyotrophic Lateral Sclerosis (ALS) Progression.Michael S McGrath, Rongzhen Zhang, Paige M Bracci, Ari Azhir, Bruce D Forrest
Biomedicines. 2024-10-16
Press Mentions
Mounting Evidence Demonstrates Neuvivo’s NP001 Spares Lung Function and Substantially Extends Survival in ALS PatientsJanuary 23rd, 2025- Significant Breakthroughs in Preserving ALS Lung Function and Survival Unveiled in Peer-Reviewed Studies of Novel Immunotherapy Platform NP001October 16th, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
